Grants paid by Three Lakes Foundation Trust
EIN 84-6979177 · IL · Form 990-PF, Part XV
Three Lakes Foundation Trust of IL (EIN 84-6979177) reported 36 grants paid totaling $11,051,714 to 20 recipients in tax years 2020–2025, on Form 990-PF, Part XV. It also reported $7,189,112 approved for future payment, which is listed separately and not included in the total. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$11,051,714
36 grants
Recipients
20
distinct organizations
Tax years
2020–2025
6 filings in the corpus
Approved for future payment
$7,189,112
10 commitments · not included in grants paid
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 4 | $1,789,761 | $3,954,781 |
| 2021 | 7 | $2,108,039 | $2,471,726 |
| 2022 | 13 | $4,038,421 | $146,285 |
| 2023 | 8 | $2,069,228 | $616,320 |
| 2024 | 3 | $628,820 | — |
| 2025 | 1 | $417,445 | — |
Top recipients
The 20 recipients receiving the most from Three Lakes Foundation Trust, by grants paid, out of 20 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| American College of Chest Physicians 36-2170783 | B | Glenview, IL | 4 | $2,382,800 | 2023 |
| Vanderbilt University Medical Center 35-2528741 | B | Nashville, TN | 4 | $1,571,720 | 2024 |
| University of Pittsburgh 52-1538538 | B | Pittsburgh, PA | 3 | $1,339,396 | 2023 |
| Yale University Development | U | New Haven, CT | 3 | $1,253,150 | 2023 |
| Innovation Development Institute 46-3253782 | B | Chicago, IL | 1 | $721,560 | 2020 |
| Pulmonary Fibrosis Foundation 84-1558631 | C | Chicago, IL | 1 | $564,532 | 2020 |
| Yale University School of Medicine | U | New Haven, CT | 1 | $524,389 | 2021 |
| University of Pittsburgh | U | Pittsburgh, PA | 1 | $424,410 | 2021 |
| New Venture Fund 20-5806345 | B | Washington, DC | 1 | $417,445 | 2025 |
| The Dallas Foundation 75-2890371 | C | Dallas, TX | 6 | $416,302 | 2023 |
| Mayo Clinic | U | Rochester, MN | 1 | $348,094 | 2020 |
| Lung Foundation Australia | U | Milton, QLD | 1 | $333,905 | 2021 |
| Lahey Hospital and Medical Center Lahey Clinic Inc | U | Burlington, MA | 2 | $292,570 | 2023 |
| University of Calgary | U | Calgary, AB | 1 | $173,129 | 2021 |
| Baylor Scott & White Dallas Foundation | U | Dallas, TX | 1 | $155,575 | 2020 |
| Cornell University - Weill Medical | U | New York, NY | 1 | $87,737 | 2022 |
| Johns Hopkins University | U | Baltimore, MD | 1 | $30,000 | 2022 |
| University of Colorado Anschutz Medical Campus | U | Aurora, CO | 1 | $10,000 | 2024 |
| Wescoe Foundation for Pf 27-4464618 | D | Coopersburg, PA | 1 | $2,500 | 2023 |
| Federation of American Societies for Experimental Biology 52-0700497 | B | Rockville, MD | 1 | $2,500 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 46 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | New Venture Fund Washington, DC | B | $417,445 | paid | Three Lakes 12 to 20 Project to support the advancement of therapies for pulmonary fibrosis. | 202630279349100583 |
| 2024 | Vanderbilt University Medical Center Nashville, TN | B | $616,320 | paid | B4PF2.0 Imaging Phase II | 202501229349101430 |
| 2024 | University of Colorado Anschutz Medical Campus Aurora, CO | U | $10,000 | paid | Thomas L. Petty Aspen Lung Conference | 202501229349101430 |
| 2024 | Federation of American Societies for Experimental Biology Rockville, MD | B | $2,500 | paid | 2024 FASEB Meeting Sponsorship | 202501229349101430 |
| 2023 | Vanderbilt University Medical Center Nashville, TN | B | $616,320 | approved, future | B4PF2.0 Imaging Phase II | 202441379349100829 |
| 2023 | American College of Chest Physicians Glenview, IL | B | $589,950 | paid | PF Education and Quality Improvement Program grant | 202441379349100829 |
| 2023 | Yale University Development New Haven, CT | U | $471,350 | paid | The Pulmonary Fibrosis Connectome | 202441379349100829 |
| 2023 | University of Pittsburgh Pittsburgh, PA | B | $457,493 | paid | Cure PF - Translational Models for Pulmonary Fibrosis | 202441379349100829 |
| 2023 | American College of Chest Physicians Glenview, IL | B | $196,650 | paid | PF Education and Quality Improvement Program grant - Year 2 Clinical Engagement | 202441379349100829 |
| 2023 | Lahey Hospital and Medical Center - Lahey Clinic Inc Burlington, MA | U | $146,285 | paid | Lung Health Clinic: Clinical Screening | 202441379349100829 |
| 2023 | The Dallas Foundation Dallas, TX | C | $102,500 | paid | PF Warriors Sustainability Grant 2023 | 202441379349100829 |
| 2023 | The Dallas Foundation Dallas, TX | C | $102,500 | paid | PF Warriors Sustainability Grant 2023 | 202441379349100829 |
| 2023 | Wescoe Foundation for Pf Coopersburg, PA | D | $2,500 | paid | Survey of PFF Patients and Families | 202441379349100829 |
| 2022 | American College of Chest Physicians Glenview, IL | B | $905,600 | paid | 1ST INSTALLMENT FOR THE "PF EDUCATION AND QUALITY IMPROVEMENT PROGRAM" | 202321319349105272 |
| 2022 | American College of Chest Physicians Glenview, IL | B | $690,600 | paid | 2ND INSTALLMENT FOR THE "PF EDUCATION AND QUALITY IMPROVEMENT PROGRAM" | 202321319349105272 |
| 2022 | Yale University Development New Haven, CT | U | $457,618 | paid | THE PULMONARY FIBROSIS CONNECTOME | 202321319349105272 |
| 2022 | University of Pittsburgh Pittsburgh, PA | B | $457,492 | paid | CUREPF-TRANSLATIONAL MODELS FOR PULMONARY FIBROSIS | 202321319349105272 |
| 2022 | University of Pittsburgh Pittsburgh, PA | B | $424,411 | paid | CUREPF-TRANSLATIONAL MODELS FOR PULMONARY FIBROSIS | 202321319349105272 |
| 2022 | Vanderbilt University Medical Center Nashville, TN | B | $346,830 | paid | DEFINING THE MOLECULAR PATHOGENESIS OF EARLY PULMONARY FIBROSIS | 202321319349105272 |
| 2022 | Yale University Development New Haven, CT | U | $324,182 | paid | THE PULMONARY FIRBROSIS CONNECTOME | 202321319349105272 |
| 2022 | Lahey Hospital and Medical Center Lahey Clinic Inc Burlington, MA | U | $146,285 | paid | LUNG HEALTH CLINIC: CLINICAL SCREENING | 202321319349105272 |
| 2022 | Lahey Hospital and Medical Center Lahey Clinic Inc Burlington, MA | U | $146,285 | approved, future | LUNG HEALTH CLINIC: CLINICAL SCREENING | 202321319349105272 |
| 2022 | Cornell University - Weill Medical New York, NY | U | $87,737 | paid | B4PF2.0 IMAGING INITIATIVE | 202321319349105272 |
| 2022 | The Dallas Foundation Dallas, TX | C | $75,000 | paid | PF WARRIORS - GENERAL OPERATING SUPPORT 2021-2022 | 202321319349105272 |
| 2022 | Vanderbilt University Medical Center Nashville, TN | B | $62,337 | paid | B4PF2.0 IMAGING INITIATIVE | 202321319349105272 |
| 2022 | The Dallas Foundation Dallas, TX | C | $30,329 | paid | MATCHING GRANT | 202321319349105272 |
| 2022 | Johns Hopkins University Baltimore, MD | U | $30,000 | paid | HEALING BREATH PROJECT | 202321319349105272 |
| 2021 | American College of Chest Physicians Glenview, IL | B | $1,596,200 | approved, future | PF EDUCATION AND QUALITY IMPROVEMENT PROGRAM | 202201369349100435 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | B | $546,233 | paid | DEFINING THE MOLECULAR PATHOGENESIS OF EARLY PULMONARY FIBROSIS | 202201369349100435 |
| 2021 | Yale University School of Medicine New Haven, CT | U | $524,389 | paid | THE PULMONARY FIBROSIS CONNECTOME | 202201369349100435 |
| 2021 | University of Pittsburgh Pittsburgh, PA | U | $424,410 | paid | CUREPF-TRANSLATIONAL MODELS FOR PULMONARY FIBROSIS | 202201369349100435 |
| 2021 | Vanderbilt University Medical Center Nashville, TN | B | $346,830 | approved, future | DEFINING THE MOLECULAR PATHOGENESIS OF EARLY PULMONARY FIBROSIS | 202201369349100435 |
| 2021 | Lung Foundation Australia Milton, QLD | U | $333,905 | paid | CENTER OF RESEARCH EXCELLENCE IN PULMONARY FIBROSIS (CRE-PF) | 202201369349100435 |
| 2021 | Lahey Hospital and Medical Center Burlington, MA | U | $274,696 | approved, future | LUNG HEALTH CLINIC: CLINICAL SCREENING | 202201369349100435 |
| 2021 | Pulmonary Fibrosis Foundation Chicago, IL | C | $179,000 | approved, future | FDA ENGAGEMENT TO ACCELERATE PF TREATMENTS | 202201369349100435 |
| 2021 | University of Calgary Calgary, AB | U | $173,129 | paid | EXPOSURE QUESTIONNAIRE FOR PULMONARY FIBROSIS | 202201369349100435 |
| 2021 | The Dallas Foundation Dallas, TX | C | $75,000 | approved, future | PF WARRIORS - GENERAL OPERATING SUPPORT 2021-2022 | 202201369349100435 |
| 2021 | The Dallas Foundation Dallas, TX | C | $74,473 | paid | PF WARRIORS - GENERAL OPERATING SUPPORT 2021-2022 | 202201369349100435 |
| 2021 | The Dallas Foundation Dallas, TX | C | $31,500 | paid | PF WARRIORS - GAP FUNDING | 202201369349100435 |
| 2020 | Yale University School of Medicine New Haven, CT | U | $1,777,539 | approved, future | THE PULMONARY FIBROSIS CONNECTOME | 202133079349101543 |
| 2020 | University of Pittsburgh Pittsburgh, PA | U | $1,763,806 | approved, future | CURE PF - TRANSLATIONAL MODELS FOR PULMONARY FIBROSIS | 202133079349101543 |
| 2020 | Innovation Development Institute Chicago, IL | B | $721,560 | paid | PF INNOVATION CHALLENGE AND FORUM | 202133079349101543 |
| 2020 | Pulmonary Fibrosis Foundation Chicago, IL | C | $564,532 | paid | OXYGEN INITIATIVE AND PROGRAM SUPPORT | 202133079349101543 |
| 2020 | Baylor Scott & White Dallas Foundation Dallas, TX | U | $413,436 | approved, future | PATHFINDERS - INTERSTITIAL LUNG DISEASE SUPPLEMENTAL CARE PROGRAM | 202133079349101543 |
| 2020 | Mayo Clinic Rochester, MN | U | $348,094 | paid | TO IMPROVE AWARENESS AND TIME TO DIAGNOSIS FOR PATIENTS WITH IPF | 202133079349101543 |
| 2020 | Baylor Scott & White Dallas Foundation Dallas, TX | U | $155,575 | paid | PATHFINDERS - INTERSTITIAL LUNG DISEASE SUPPLEMENTAL CARE PROGRAM | 202133079349101543 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2025 | 2025-08-01 | not stated | 2024v5.1 | 202630279349100583 |
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.1 | 202501229349101430 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.0 | 202441379349100829 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202321319349105272 |
| 990PF | 2021 | 2021-12-31 | not stated | 2021v4.2 | 202201369349100435 |
| 990PF | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202133079349101543 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/846979177.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.